Stocks to Watch: Hero Motocorp, Paytm, Indian Hotells, Abbott India

Hero MotoCorp: Achieves Robust Growth with 21.6% YoY Increase in January Sales

Hero MotoCorp, a leading two-wheeler manufacturer, reported an impressive performance in January, recording a total sales figure of 4,33,598 units. This marks a substantial 21.6% increase from the same period last year. The domestic market contributed significantly to this growth, witnessing a 20.5% surge in sales, reaching 4.2 lakh units. Additionally, the company experienced a remarkable 74.6% YoY surge in exports, totaling 12,664 units.

Paytm: Faces Setback as RBI Actions Prompt Operational Changes

During an analyst call, Paytm’s management acknowledged the challenges posed by recent actions from the Reserve Bank of India (RBI), referring to them as a significant speed bump. Consequently, the company anticipates the need for operational changes. The impact of these developments was reflected in the stock performance, which hit a 20% lower circuit soon after the market opened on Thursday.

Indian Hotels: Strong Q3 Performance with Double-Digit Growth

Indian Hotels reported a robust financial performance in Q3, with a notable 18.2% YoY increase in net profit, amounting to ₹476.9 crore. The company also saw a 16.5% growth in revenue, supported by a 22.6% YoY increase in Ebitda and a margin of 37.3%. Room revenue played a significant role, contributing to a 21% growth. The international segment experienced a 9% YoY growth in RevPAR, driven by a 70% occupancy level.

Abbott India: Impressive Growth in Q3 Net Profit and Revenue

Abbott India posted a commendable 26% growth in net profit, reaching ₹311 crore for the quarter ending December. The revenue from operations also exhibited a strong performance, growing by 8.7% to ₹1,437 crore compared to the same period last year.

Mphasis: Sees Signs of Stability Amid Seasonal Softness

Mphasis reported a 2% sequential increase in direct revenue and a 1.3% growth in constant currency terms. Despite seasonal softness in the quarter, the company remains optimistic, citing signs of stability. Notably, new deal wins amounted to $241 million.

Eicher Motors: Royal Enfield Sales Rise, Exports Decline

Eicher Motors’ flagship brand, Royal Enfield, recorded a 2% YoY increase in motorcycle sales for January, reaching 76,187 units. However, the export segment faced a decline of 20%, with sales totaling 5,631 motorcycles.

Panacea Biotec: USFDA Action on Subsidiary’s Facility Inspection

The US Food and Drug Administration (USFDA) has classified the inspection of Panacea Biotec Pharma’s facility in Baddi, Himachal Pradesh, as ‘official action indicated.’

Sonata Software: Reports Net Loss in December Quarter

Sonata Software faced a net loss of ₹46.2 crore in the December quarter, contrasting with a profit of ₹124.2 crore in the previous quarter. However, the consolidated revenue from operations displayed a 30.4% sequential growth, reaching ₹2,493.3 crore.

Bata India: Q3 Net Profit Declines Amid Tepid Topline

Bata India reported a net profit of ₹57.3 crore in the December quarter, reflecting a 31% YoY decline. The modest growth of 0.4% in revenue from operations, totaling ₹903.5 crore, contributed to the challenging operating numbers.

Disclaimer: The views and investment tips expressed by investment experts on Sharepriceindia.com are their own and not those of the website or its management. Sharepriceindia.com advises users to check with certified experts before taking any investment decisions.​​
Daily Index & Stock Option Research On Whatsapp
We will be happy to hear your thoughts

      Leave a reply

      Share Price India News
      Logo